Research Topics
| Kohei NakachiSummaryAffiliation: National Cancer Center Country: Japan Publications
| Collaborators
|
Detail Information
Publications
A phase II study of induction chemotherapy with gemcitabine plus S-1 followed by chemoradiotherapy for locally advanced pancreatic cancerKohei Nakachi
Division of Hepatobiliary, National Cancer Center Hospital East, 6 5 1 Kashiwanoha, Kashiwa, Chiba, 277 8577, Japan
Cancer Chemother Pharmacol 66:527-34. 2010..The aim of this study was to investigate the feasibility and efficacy of induction chemotherapy with gemcitabine and S-1 followed by chemoradiotherapy for locally advanced pancreatic cancer...
Prognostic factors in patients with gemcitabine-refractory pancreatic cancerKohei Nakachi
Division of Hepatobiliary and Pancreatic Medical Oncology, National Cancer Center Hospital East, Kashiwa, Chiba, Japan
Jpn J Clin Oncol 37:114-20. 2007..The purpose of this study was to identify prognostic factors in patients with gemcitabine-refractory pancreatic cancer and to determine criteria for selecting candidates for second-line treatment...
Guidelines for chemotherapy of biliary tract and ampullary carcinomasJunji Furuse
Hepatobiliary and Pancreatic Oncology Division, National Cancer Center Hospital East, Kashiwa shi, Chiba, Japan
J Hepatobiliary Pancreat Surg 15:55-62. 2008..It is recommended that further clinical trials, especially large multi-institutional RCTs (phase III studies) using novel agents such as gemcitabine should be performed as soon as possible in order to establish a standard treatment...
Treatment efficacy/safety and prognostic factors in patients with advanced biliary tract cancer receiving gemcitabine monotherapy: an analysis of 100 casesEiichiro Suzuki
Division of Hepatobiliary and Pancreatic Oncology, National Cancer Center Hospital East, Chiba, Japan
Oncology 79:39-45. 2010..The purpose of this study was to elucidate the treatment efficacy and safety of gemcitabine monotherapy, and to identify prognostic factors in patients with advanced biliary tract cancer receiving this therapy...
Stenting and interventional radiology for obstructive jaundice in patients with unresectable biliary tract carcinomasToshio Tsuyuguchi
Department of Medicine and Clinical Oncology, Chiba University Graduate School of Medicine, Chiba, Japan
J Hepatobiliary Pancreat Surg 15:69-73. 2008..In spite of these shortcomings, evidence is expected to demonstrate its superiority over other types of stent...
Phase I/II study of the pharmacokinetics, safety and efficacy of S-1 in patients with advanced hepatocellular carcinomaJunji Furuse
Hepatobiliary and Pancreatic Oncology Division, National Cancer Center Hospital East, Kashiwa, Japan
Cancer Sci 101:2606-11. 2010..In conclusion, S-1 showed an acceptable toxicity profile and promising antitumor activity for hepatocellular carcinoma, warranting further evaluation in randomized clinical trials...
Early phase II study of uracil-tegafur plus doxorubicin in patients with unresectable advanced biliary tract cancerJunji Furuse
National Cancer Center Hospital East, Kashiwa, Chiba 277 8577, Japan
Jpn J Clin Oncol 36:552-6. 2006..The purpose of this study was to evaluate the efficacy and toxicity of a combination chemotherapy of uracil-tegafur (UFT) and doxorubicin in patients with unresectable advanced biliary tract cancer...
Transcatheter arterial infusion chemotherapy with a fine-powder formulation of cisplatin for advanced hepatocellular carcinoma refractory to transcatheter arterial chemoembolizationSatoru Iwasa
Division of Hepatobiliary and Pancreatic Oncology, National Cancer Center Hospital East, 6 5 1 Kashiwanoha, Kashiwa, Chiba 277 8577, Japan
Jpn J Clin Oncol 41:770-5. 2011....
[Chemotherapy]Masafumi Ikeda
Division of Hepatobiliary and Pancreatic Oncology, National Cancer Center Hospital East, Kashiwa, Chiba, Japan
Gan To Kagaku Ryoho 37:408-12. 2010..After the introduction of sorafenib, chemotherapy for advanced hepatocellular carcinoma has been changing remarkably, and further improvements of chemotherapy for hepatocellular carcinoma are expected...
A phase I study of hypofractionated radiotherapy followed by systemic chemotherapy with full-dose gemcitabine in patients with unresectable locally advanced pancreatic cancerJunji Furuse
Division of Hepatobiliary and Pancreatic Oncology, National Cancer Center Hospital East, Chiba, Japan
Hepatogastroenterology 54:1575-8. 2007..The purpose of this study was to determine the feasible dose of hypofractionated radiotherapy that could be followed by full-dose gemcitabine in patients with locally advanced pancreatic cancer...
Phase I trial of a glypican-3-derived peptide vaccine for advanced hepatocellular carcinoma: immunologic evidence and potential for improving overall survivalYu Sawada
Section for Cancer Immunotherapy, Investigative Treatment Division, Research Center for Innovative Oncology, National Cancer Center Hospital East, Kashiwa, Chiba, Japan
Clin Cancer Res 18:3686-96. 2012..In this nonrandomized, open-label, phase I clinical trial, we analyzed the safety and efficacy of GPC3 peptide vaccination in patients with advanced HCC...
Borderline resectable pancreatic cancer: rationale for multidisciplinary treatmentShinichiro Takahashi
Department of Hepatobiliary Pancreatic Surgery, National Cancer Center Hospital East, 6 5 1 Kashiwanoha, Kashiwa, Chiba, 277 8577, Japan
J Hepatobiliary Pancreat Sci 18:567-74. 2011..However, few reports are available on differences in tumor characteristics and prognoses among resectable pancreatic cancer (PC), BRPC, and unresectable PC...
Dose-volume histogram analysis of the safety of proton beam therapy for unresectable hepatocellular carcinomaMitsuhiko Kawashima
Division of Particle Therapy and Radiation Oncology, Research Center for Innovative Oncology, National Cancer Center Hospital East, Kashiwa, Japan
Int J Radiat Oncol Biol Phys 79:1479-86. 2011..To evaluate the safety and efficacy of radiotherapy using proton beam (PRT) for unresectable hepatocellular carcinoma...
Hepatectomy for hepatocellular carcinoma patients who meet the Milan criteriaHiroshi Ishii
Division of Hepatobiliary and Pancreatic Medical Oncology, National Cancer Center Hospital East, Kashiwa, Japan
Hepatogastroenterology 55:621-6. 2008..Although hepatocellular carcinoma patients who meet the Milan criteria are optimal candidates for liver transplantation, most such patients in Japan have been treated without liver transplantation...
Phase I study of fixed dose rate infusion of gemcitabine in patients with unresectable pancreatic cancerJunji Furuse
Division of Hepatobiliary and Pancreatic Medical Oncology, National Cancer Center Hospital East, Kashiwa, Chiba 277 8577, Japan
Jpn J Clin Oncol 35:733-8. 2005..The purpose of this study was to determine the feasible dose of gemcitabine when administered as a fixed dose rate infusion (10 mg/m(2)/min) on a weekly schedule to Japanese patients with unresectable advanced pancreatic cancer...
Radiofrequency ablation for hepatocellular carcinoma induces glypican-3 peptide-specific cytotoxic T lymphocytesDaisuke Nobuoka
Section for Cancer Immunotherapy, Investigative Treatment Division, Research Center for Innovative Oncology, National Cancer Center Hospital East, 6 5 1 Kashiwanoha, Kashiwa, Chiba 277 8577, Japan
Int J Oncol 40:63-70. 2012..Combined treatment of RFA and immunotherapy is a reasonable strategy against HCC...
Phase I study of sorafenib in Japanese patients with hepatocellular carcinomaJunji Furuse
Division of Hepatobiliary and Pancreatic Medical Oncology, National Cancer Center Hospital East, 6 5 1 Kashiwanoha, Kashiwa, Chiba 277 8577, Japan
Cancer Sci 99:159-65. 2008..Moreover, promising preliminary antitumor activity has been observed. Finally, there were no clinically relevant differences in PK between Child-Pugh A and B patients...
A phase II study of S-1 in gemcitabine-refractory metastatic pancreatic cancerChigusa Morizane
Division of Hepatobiliary and Pancreatic Oncology, National Cancer Center Hospital, 5 1 1 Tsukiji, Chuo Ku, Tokyo 104 0045, Japan
Cancer Chemother Pharmacol 63:313-9. 2009..5% in chemo-naïve patients with pancreatic cancer. This study evaluated the efficacy and toxicity of S-1 in patients with gemcitabine-refractory metastatic pancreatic cancer...
A phase I study of combination chemotherapy with gemcitabine and oral S-1 for advanced pancreatic cancerHideki Ueno
Hepatobiliary and Pancreatic Oncology Division, National Cancer Center Hospital, Tokyo, Japan
Oncology 69:421-7. 2005..The aim of this study was to determine the maximum-tolerated dose and dose-limiting toxicity (DLT) of combination therapy with gemcitabine and S-1 in patients with advanced pancreatic cancer...
Phase II study of erlotinib plus gemcitabine in Japanese patients with unresectable pancreatic cancerTakuji Okusaka
National Cancer Center Hospital, Tokyo, Japan
Cancer Sci 102:425-31. 2011..3% and 50.0%, respectively. In Japanese patients with unresectable pancreatic cancer, erlotinib plus gemcitabine had acceptable toxicity and efficacy that was not inferior to that seen in Western patients...
Neural invasion induces cachexia via astrocytic activation of neural route in pancreatic cancerAkira Imoto
Pathology Division, Research Center for Innovative Oncology, National Cancer Center Hospital East, Kashiwa, Chiba, Japan Department of Internal Medicine, Osaka Medical College, Takatsuki, Osaka, Japan
Int J Cancer 131:2795-807. 2012..These data provide the first evidence that N-inv induces cachexia via astrocytic activation of neural route in pancreatic cancer...
Risk factors for biliary tract and ampullary carcinomas and prophylactic surgery for these factorsMasaru Miyazaki
Department of General Surgery, Chiba University Graduate School of Medicine, Chiba, Japan
J Hepatobiliary Pancreat Surg 15:15-24. 2008..This article discusses the risk factors for cancerous and precancerous lesions of the biliary tract and prophylactic treatment for these factors...
[Treatments of pancreatic cancer from the standpoint of medical oncology]Junji Furuse
Division of Hepatobiliary and Pancreatic Oncology, National Cancer Center Hospital East
Gan To Kagaku Ryoho 34:997-1001. 2007..Furthermore, second-line chemotherapy regimens for use after GEM chemotherapy should be investigated to improve the survival of patients with advanced pancreatic cancer...
[Unresectable gallbladder cancer with lymph node and liver metastases completely responding to S-1 monotherapy - a case report]Junji Furuse
Division of Hepatobiliary and Pancreatic Oncology, National Cancer Center Hospital East
Gan To Kagaku Ryoho 34:1679-82. 2007..Grade 2 anorexia, diarrhea, hand-foot skin reaction, and tasty disturbance were observed, but no grade 3 or more toxicities were noted. S-1 appeared to be effective against advanced gallbladder cancer and showed excellent tolerability...
Guidelines for the management of biliary tract and ampullary carcinomas: surgical treatmentSatoshi Kondo
Department of Surgical Oncology, Hokkaido University Graduate School of Medicine, Sapporo, Japan
J Hepatobiliary Pancreat Surg 15:41-54. 2008..The prognostic factors after resection for ampullary carcinoma include lymph node metastasis, pancreatic invasion, and perineural invasion...
Purpose, use, and preparation of clinical practice guidelines for the management of biliary tract and ampullary carcinomasTadahiro Takada
Department of Surgery, Teikyo University School of Medicine, Tokyo, Japan
J Hepatobiliary Pancreat Surg 15:2-6. 2008..The grading of the recommendations is based on the determination of the level of evidence in references on which the recommendation is based...
Flowcharts for the management of biliary tract and ampullary carcinomasShuichi Miyakawa
Department of Gastroenterological Surgery, Fujita Health University, Kutsukake cho, Toyoake, Aichi, Japan
J Hepatobiliary Pancreat Surg 15:7-14. 2008..In those with nonresectable disease, biliary stenting, chemotherapy, radiotherapy, and/or best supportive care is selected...
Preoperative biliary drainage for biliary tract and ampullary carcinomasMasato Nagino
Division of Surgical Oncology, Department of Surgery, Nagoya University Graduate School of Medicine, Nagoya, Japan
J Hepatobiliary Pancreat Surg 15:25-30. 2008..Thus, preoperative bile replacement in patients with external biliary drainage is very likely to be effective when highly invasive surgery (e.g., extended hepatectomy for hilar cholangiocarcinoma) is planned...
Diagnosis of biliary tract and ampullary carcinomasKazuhiro Tsukada
Department of Surgery and Science, Graduate School of Medicine and Pharmaceutical Science for Research, University of Toyama, 2630 Sugitani, Toyama 930 0194, Japan
J Hepatobiliary Pancreat Surg 15:31-40. 2008..However, direct biliary tract imaging is necessary for making a precise diagnosis of the horizontal extension of bile duct cancer...
Radiation therapy and photodynamic therapy for biliary tract and ampullary carcinomasHiroya Saito
Department of Radiology, Asahikawa Kosei General Hospital, Asahikawa 078 8211, Japan
J Hepatobiliary Pancreat Surg 15:63-8. 2008..Results from large RCTs are desired...
